This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Take Your Nursing Practice to the Next Level
View analytic
Friday, April 24 • 10:30am - 12:00pm
Evaluating Risk for Hereditary Cancer Syndromes (Cancer Genetics SIG)

Sign up or log in to save this to your schedule and see who's attending!

Review the procedural, technological, and commercial factors that have impacted the field of cancer risk evaluation for inherited cancer syndromes in the past 18 months. You’ll become familiar with the rapid expansion of commercial testing laboratories providing germline testing for hereditary cancer syndromes and the use of next-generation sequencing. Leave with an understanding of the complexities faced by clinicians when determining patient eligibility for genetic testing, with third-party payers now determining eligibility and directing testing service accessibility.


  1. Delineate the impact of next generation sequencing technology on the landscape of cancer risk Assessment for inherited cancer syndromes and the development of targeted therapies in many types of cancers.


Cathy Belt, RN, MSN, AOCN®

Senior Administrator, Penn Cancer Network, Penn Medicine Abramson Cancer Center
Cancer Genetic SIG Chair - 2014-2016 | Area of specialization - Cancer risk assessment and hereditary cancer syndromes | If you need assistance in trying to implement a risk program please contact me: | Cathy.belt@uphs.upenn.edu

Friday April 24, 2015 10:30am - 12:00pm
314A 9800 International Drive, Orlando, FL 32819

Attendees (149)